Seven Eight Capital’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-152,604
| Closed | -$1.63M | – | 232 |
|
|
2024
Q3 | $1.63M | Buy |
152,604
+93
| +0.1% | +$993 | 0.15% | 238 |
|
|
2024
Q2 | $1.51M | Sell |
152,511
-8,837
| -5% | -$87.7K | 0.16% | 218 |
|
|
2024
Q1 | $1.9M | Buy |
161,348
+20,767
| +15% | +$245K | 0.2% | 154 |
|
|
2023
Q4 | $1.99M | Buy |
140,581
+106,541
| +313% | +$1.51M | 0.23% | 125 |
|
|
2023
Q3 | $414K | Sell |
34,040
-29,538
| -46% | -$359K | 0.05% | 432 |
|
|
2023
Q2 | $799K | Buy |
63,578
+53,159
| +510% | +$668K | 0.13% | 219 |
|
|
2023
Q1 | $116K | Buy |
+10,419
| New | +$116K | 0.02% | 410 |
|
|
2022
Q4 | – | Sell |
-26,303
| Closed | -$275K | – | 488 |
|
|
2022
Q3 | $275K | Buy |
+26,303
| New | +$275K | 0.06% | 401 |
|
|
2022
Q2 | – | Sell |
-24,651
| Closed | -$233K | – | 465 |
|
|
2022
Q1 | $233K | Sell |
24,651
-3,283
| -12% | -$31K | 0.03% | 464 |
|
|
2021
Q4 | $323K | Buy |
27,934
+12,234
| +78% | +$141K | 0.06% | 350 |
|
|
2021
Q3 | $150K | Buy |
+15,700
| New | +$150K | 0.01% | 535 |
|
|
2021
Q2 | – | Sell |
-22,603
| Closed | -$522K | – | 626 |
|
|
2021
Q1 | $522K | Hold |
22,603
| – | – | 0.12% | 257 |
|
|
2020
Q4 | $522K | Buy |
22,603
+8,149
| +56% | +$188K | 0.12% | 260 |
|
|
2020
Q3 | $204K | Buy |
14,454
+3,700
| +34% | +$52.2K | 0.04% | 520 |
|
|
2020
Q2 | $162K | Buy |
+10,754
| New | +$162K | 0.12% | 285 |
|
|
2018
Q2 | – | Sell |
-66,755
| Closed | -$1M | – | 505 |
|
|
2018
Q1 | $1M | Sell |
66,755
-68,345
| -51% | -$1.03M | 0.08% | 225 |
|
|
2017
Q4 | $1.94M | Buy |
135,100
+19,400
| +17% | +$279K | 0.2% | 187 |
|
|
2017
Q3 | $1.75M | Buy |
115,700
+114,900
| +14,363% | +$1.73M | 0.21% | 158 |
|
|
2017
Q2 | $8K | Buy |
+800
| New | +$8K | ﹤0.01% | 527 |
|